Linking dioxins to diabetes: epidemiology and biologic plausibility.

Abstract

Recent epidemiologic studies suggest a possible association between dioxin-like compounds (DLCs) and diabetes in human populations, although experimental links between DLCs and diabetes are lacking. The public health significance of such an association is that all populations are exposed to small but measurable levels of DLCs, chronic low-dose exposure to which may hasten the onset of adult-onset diabetes in susceptible individuals. In this article, we review the epidemiologic studies and propose biologically plausible connections between dioxins and diabetes. Specifically, we suggest that aryl hydrocarbon (Ah) receptor functions may antagonize peroxisome proliferator-activated receptor (PPAR) functions, and hence that the Ah receptor may promote diabetogenesis through a mechanism of PPAR antagonism.

Cited by papers we hold 6

• New Insights Into Gut-Bacteria-Derived Indole and Its Derivatives in Intestinal and Liver Diseases · 2021
  No notice
• High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance · 2021
  No notice
• Toxicological Function of Adipose Tissue: Focus on Persistent Organic Pollutants · 2012
  No notice
• Knowns and unknowns on burden of disease due to chemicals: a systematic review · 2011
  No notice
• Integration of Genome-Wide Computation DRE Search, AhR ChIP-chip and Gene Expression Analyses of TCDD-Elicited Responses in the Mouse Liver · 2011
  No notice
• The Estrogenic Effect of Bisphenol A Disrupts Pancreatic β-Cell Function In Vivo and Induces Insulin Resistance · 2005
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.